IP and Pharma Translations Boost Q3 Results for Japan’s Largest LSP
On the back of a 16.9% growth YOY of its core Translation Business, Honyaku Center posts USD 78.68m in revenues for the first 9 months of its 2019 fiscal year. Continue reading
Tag: life sciences
TransPerfect’s Scary Good 2018
As TransPerfect posts USD 705m in full-year revenues for 2018, CEO Phil Shawe comments on the company’s record setting 2018, his M&A outlook for 2019, neural machine translation, and why Amazon... Continue reading
SlatorCon 2018—Your Definitive Guide And Key Takeaways
SlatorCon tour took in four global cities across three continents in 2018 and featured a grand total of 35 speakers representing the full breadth of the language industry from startups, language... Continue reading
How Roche’s Internal Language Service Creates Value for the Pharma Giant
Pharma and biotech giant Roche’s Claudine Nick outlined the internal and external complexities of localizing for this highly regulated industry and highlighted the value-add of having an internal... Continue reading
What RWS Told Investors About How Well Post-Editing Works in Patent Translation
Language service provider RWS tells investors at capital markets event about how it is integrating Moravia and informs about the results of a pilot project to deploy MT post-editing in production... Continue reading
Advertisement
Argos Multilingual and enLabel Global Services, Inc. Announce Strategic Partnership
Partnership will streamline the international medical labeling publishing process Continue reading
No More Muddling Through: Why 2018 Is the Language Industry’s Pivotal Year
As technology is boosting productivity and changing buyer expectations, dropping unit prices presents opportunities to vendors that bring the tech, specialization, and size to seize them but it... Continue reading
Reader Polls: Translation Rates, End-Markets, Neural MT’s Impact, Buy or Build a TMS
Slator poll-takers say life sciences is the most high-growth vertical, share very positive outlook on neural MT, reveal word rate changes in 2017, and answer whether LSPs should build or buy... Continue reading
AMPLEXOR’S Jason Arnsparger to Present at Pharma & Device Labeling Conference
AMPLEXOR'S Jason Arnsparger will present “Lost in Translation: The Case for Centralized Content Management" at the Pharma & Device Labeling Conference. Continue reading
Translation Fail Puts Chinese Pharma Company in US Regulator’s Crosshairs
Hydrocortisone or Dexamethasone? A Guangdong-based Chinese drug manufacturer gets a warning letter from the US Food and Drug Administration over a translation mistake in the label of an... Continue reading
Advertisement
RWS Expands Global Offering with RWS Life Sciences
The acquisition of LUZ, Inc. and Corporate Translations, Inc. strengthens RWS’ market leadership and continued growth of life science language services. Continue reading
ICON Buys Mapi, Targets “Growing” Language Services Market
The combination of ICON’s and Mapi’s language services groups will create a potent rival to language service providers when competing for business with big pharma. Continue reading
Takeaways: Slator’s Roundtable on Compliance and Vendor Management in Clinical Trials
With new regulations in China as well as global language issues, life sciences companies are facing new challenges in conducting clinical trials in Asia-Pacific. Continue reading
Inside Rally Health’s Complex Journey Toward Localization Maturity
Rally Health Localization Manager on how localization is considered a revenue driver at the fast-growing healthcare startup, how costs are shifting from translation to review, and how OS-agnostic... Continue reading
RWS Spends Big on 82.5m Acquisition of LUZ
One of the most attractive pure-play, life sciences players changes hands as RWS bolsters position in fast-growing vertical. Price tag in line with 2015 acquisition of CTi. Continue reading
Advertisement
This information will never be shared with third parties. No Spam.